• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模前列腺癌:一种转基因小鼠模型的视角。

Modeling prostate cancer: a perspective on transgenic mouse models.

机构信息

Oncology Research Centre, Prince of Wales Hospital, Barker St., Randwick, NSW, 2031, Australia.

出版信息

Cancer Metastasis Rev. 2010 Mar;29(1):123-42. doi: 10.1007/s10555-010-9212-9.

DOI:10.1007/s10555-010-9212-9
PMID:20143131
Abstract

Despite considerable success in treatment of early stage localized prostate cancer (PC), acute inadequacy of late stage PC treatment and its inherent heterogeneity poses a formidable challenge. Clearly, an improved understanding of PC genesis and progression along with the development of new targeted therapies are warranted. Animal models, especially, transgenic immunocompetent mouse models, have proven to be the best ally in this respect. A series of models have been developed by modulation of expression of genes implicated in cancer-genesis and progression; mainly, modulation of expression of oncogenes, steroid hormone receptors, growth factors and their receptors, cell cycle and apoptosis regulators, and tumor suppressor genes have been used. Such models have contributed significantly to our understanding of the molecular and pathological aspects of PC initiation and progression. In particular, the transgenic mouse models based on multiple genetic alterations can more accurately address the inherent complexity of PC, not only in revealing the mechanisms of tumorigenesis and progression but also for clinically relevant evaluation of new therapies. Further, with advances in conditional knockout technologies, otherwise embryonically lethal gene changes can be incorporated leading to the development of new generation transgenics, thus adding significantly to our existing knowledge base. Different models and their relevance to PC research are discussed.

摘要

尽管在治疗早期局限性前列腺癌 (PC) 方面取得了相当大的成功,但晚期 PC 治疗的急性不足及其固有的异质性仍然构成了严峻的挑战。显然,需要更好地了解 PC 的发生和发展,并开发新的靶向治疗方法。在这方面,动物模型,特别是转基因免疫功能正常的小鼠模型,已被证明是最好的盟友。通过调节与癌症发生和发展相关的基因的表达,已经开发出一系列模型;主要是,调节癌基因、甾体激素受体、生长因子及其受体、细胞周期和凋亡调节剂以及肿瘤抑制基因的表达。这些模型为我们理解 PC 起始和发展的分子和病理方面做出了重大贡献。特别是,基于多种遗传改变的转基因小鼠模型可以更准确地解决 PC 的固有复杂性,不仅可以揭示肿瘤发生和发展的机制,还可以对新疗法进行临床相关评估。此外,随着条件性基因敲除技术的进步,原本在胚胎期就会致死的基因变化也可以被引入,从而开发出新一代的转基因动物,从而大大增加了我们现有的知识库。讨论了不同的模型及其与 PC 研究的相关性。

相似文献

1
Modeling prostate cancer: a perspective on transgenic mouse models.建模前列腺癌:一种转基因小鼠模型的视角。
Cancer Metastasis Rev. 2010 Mar;29(1):123-42. doi: 10.1007/s10555-010-9212-9.
2
New prospectives of prostate cancer gene therapy: molecular targets and animal models.前列腺癌基因治疗的新前景:分子靶点与动物模型
Crit Rev Eukaryot Gene Expr. 2001;11(1-3):77-120.
3
Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.前列腺癌基因工程小鼠模型综述:分析前列腺癌发生、发展和转移的分子基础。
J Cell Biochem. 2005 Feb 1;94(2):279-97. doi: 10.1002/jcb.20339.
4
Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.转基因小鼠及其在前列腺癌治疗策略开发中的应用。
J Urol. 2004 Jul;172(1):12-9. doi: 10.1097/01.ju.0000132122.93436.aa.
5
Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.非甾体抗炎药在转基因腺癌小鼠前列腺模型中对小鼠前列腺上皮内瘤变的消退作用
Clin Cancer Res. 2004 Nov 15;10(22):7727-37. doi: 10.1158/1078-0432.CCR-04-0732.
6
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.重组痘病毒用于前列腺癌免疫治疗的前景与局限性
Curr Opin Mol Ther. 1999 Aug;1(4):471-9.
7
Transgenic mouse models for the prevention of breast cancer.用于预防乳腺癌的转基因小鼠模型。
Mutat Res. 2005 Aug 25;576(1-2):93-110. doi: 10.1016/j.mrfmmm.2004.10.013.
8
OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model.OSU-HDAC42是一种组蛋白去乙酰化酶抑制剂,可阻断小鼠前列腺转基因腺癌模型中的前列腺肿瘤进展。
Cancer Res. 2008 May 15;68(10):3999-4009. doi: 10.1158/0008-5472.CAN-08-0203.
9
Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.C3(1)/Tag转基因小鼠模型中乳腺癌和前列腺癌发生过程中的基因改变。
Int J Oncol. 1998 Feb;12(2):449-53.
10
Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.前列腺肿瘤发生的机制:转录因子Nkx3.1和Egr1的作用。
Ann N Y Acad Sci. 2005 Nov;1059:33-40. doi: 10.1196/annals.1339.018.

引用本文的文献

1
Multi-omic profiling reveals an RNA processing rheostat that predisposes to prostate cancer.多组学分析揭示了一种预先存在的 RNA 处理变阻器,可能导致前列腺癌。
EMBO Mol Med. 2023 Jun 7;15(6):e17463. doi: 10.15252/emmm.202317463. Epub 2023 Apr 24.
2
Alzheimer's Disease, and Breast and Prostate Cancer Research: Translational Failures and the Importance to Monitor Outputs and Impact of Funded Research.阿尔茨海默病以及乳腺癌和前列腺癌研究:转化失败以及监测资助研究的产出和影响的重要性。
Animals (Basel). 2020 Jul 14;10(7):1194. doi: 10.3390/ani10071194.
3
A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.
一种微小RNA/Runx1/Runx2网络调控TRAMP小鼠前列腺肿瘤从发病到腺癌的进展。
Oncotarget. 2016 Oct 25;7(43):70462-70474. doi: 10.18632/oncotarget.11992.
4
Dissection of Individual Prostate Lobes in Mouse Models of Prostate Cancer to Obtain High Quality RNA.在前列腺癌小鼠模型中解剖单个前列腺叶以获取高质量RNA。
J Cell Physiol. 2017 Jan;232(1):14-8. doi: 10.1002/jcp.25384. Epub 2016 Apr 1.
5
Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse () anterior prostate.在NOD-SCIDγ小鼠前前列腺中建立人转移性前列腺癌原位模型。
Oncol Lett. 2015 Oct;10(4):2142-2148. doi: 10.3892/ol.2015.3522. Epub 2015 Jul 22.
6
Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.在小鼠前列腺中删除 atbf1/zfhx3 会导致肿瘤病变,可能是通过膜和分泌蛋白以及多种信号通路的衰减。
Neoplasia. 2014 May;16(5):377-89. doi: 10.1016/j.neo.2014.05.001. Epub 2014 Jun 14.
7
Transgenic Mouse Studies to Understand the Regulation, Expression and Function of the Testis-Specific Protein Y-Encoded (TSPY) Gene.转基因小鼠研究理解睾丸特异性蛋白 Y 编码(TSPY)基因的调控、表达和功能。
Genes (Basel). 2010 Aug 18;1(2):244-62. doi: 10.3390/genes1020244.
8
A novel method for somatic transgenesis of the mouse prostate using the Sleeping Beauty transposon system.利用 Sleeping Beauty 转座子系统对小鼠前列腺进行体细胞核移植的新方法。
Prostate. 2014 May;74(7):781-91. doi: 10.1002/pros.22797. Epub 2014 Mar 20.
9
Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer.Y 染色体定位的人类原癌基因 TSPY 在前列腺癌转基因小鼠模型中的表达。
Cell Biosci. 2014 Feb 17;4(1):9. doi: 10.1186/2045-3701-4-9.
10
Mouse models of prostate cancer: picking the best model for the question.前列腺癌小鼠模型:为问题选择最佳模型。
Cancer Metastasis Rev. 2014 Sep;33(2-3):377-97. doi: 10.1007/s10555-013-9487-8.